NeuroPace (NPCE) Share-based Compensation (2020 - 2026)
NeuroPace (NPCE) posted Share-based Compensation of $2.3 million for Q2 2026, up 1.1% on a QoQ basis from $2.3 million in Q1 2026, and down 28.66% year-over-year from $3.2 million in Q2 2025.
Analysis
NeuroPace (NPCE) Share-based Compensation (2020 - 2026) Analysis & Trends
NeuroPace has reported Share-based Compensation for 7 years, with the latest figure at $2.3 million in Q2 2026.
- On a quarterly basis, Share-based Compensation fell 28.66% year-over-year to $2.3 million in Q2 2026; TTM through Jun 2026 was $9.8 million, a 11.15% decrease from a year earlier, with the FY2025 full-year figure at $11.1 million, up 7.85% from the prior year.
- Share-based Compensation was $2.3 million for Q2 2026 at NeuroPace, up from $2.3 million in the prior quarter.
- The five-year high for Share-based Compensation was $6.5 million in Q3 2022, with the low at $115000.0 in Q4 2022.
- Average Share-based Compensation over 5 years is $2.6 million, with a median of $2.6 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Share-based Compensation slumped 93.87% in 2022, then jumped 1949.57% in 2023.
- Over 5 years, Share-based Compensation stood at $115000.0 in 2022, then surged by 1949.57% to $2.4 million in 2023, then gained by 10.44% to $2.6 million in 2024, then rose by 0.15% to $2.6 million in 2025, then declined by 11.66% to $2.3 million in 2026.
- The last three Share-based Compensation figures came in at $2.3 million (Q2 2026), $2.3 million (Q1 2026), and $2.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 12.80 Mn |
| 10 | NeuroPace | 493.15 Mn | 441.45 Mn | 18.91 Mn | 2.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.30 Mn |
| Mar 31, 2026 | 2.28 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Sep 30, 2025 | 2.63 Mn |
| Jun 30, 2025 | 3.23 Mn |
| Mar 31, 2025 | 2.63 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Sep 30, 2024 | 2.59 Mn |
| Jun 30, 2024 | 2.55 Mn |
| Mar 31, 2024 | 2.54 Mn |
| Dec 31, 2023 | 2.36 Mn |
| Sep 30, 2023 | 2.42 Mn |
| Jun 30, 2023 | 2.66 Mn |
| Mar 31, 2023 | 2.13 Mn |
| Dec 31, 2022 | 115,000.00 |
| Sep 30, 2022 | 6.49 Mn |
| Jun 30, 2022 | 2.60 Mn |
| Mar 31, 2022 | 1.49 Mn |
| Dec 31, 2021 | 1.88 Mn |
| Sep 30, 2021 | 1.11 Mn |